Joseph Loscalzo sold $1.2M of Ionis Pharmaceuticals (IONS)

Executed Oct 31 2025, disclosed Nov 3 2025, 3 days later.

Value, as filed

$1.2M

16,000 sh × $75.10

Executed

Oct 31 2025

the trade date, as filed

Disclosed

Nov 3 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JL Joseph Loscalzo Director profile →

Joseph Loscalzo (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Ionis Pharmaceuticals, Inc. (IONS). The largest single filing was $5.8M of IONS (77,289 sh across 2 lots, as filed), executed May 4.

The name

IONS Ionis Pharmaceuticals, Inc. IONS · Healthcare · 119 filings in 24 months ticker →

Healthcare · Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Joseph Loscalzo in IONS

IONSSALE Ionis Pharmaceuticals, Inc. $5.8M
77,289 sh across 2 lots
Exec May 4
Filed May 6 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $962K
16,000 sh × $60.15
Exec Sep 3 2025
Filed Sep 4 2025 · 5:30 PM ET IONSSALE Ionis Pharmaceuticals, Inc. $511K
13,508 sh × $37.86
Exec Nov 12 2024
Filed Nov 14 2024 · 5:30 PM ET